Pactiv General Employee Benefit Trust Danaher Corp Transaction History

Pactiv General Employee Benefit Trust

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$272.21 - $332.43 $91.6 Million - $112 Million	-336,441 Closed	0 $0
Q2 2021 Aug 12, 2021	SELL	$225.08 - $271.69 $74.6 Million - $90 Million	-331,369 Reduced 49.62%	336,441 $90.3 Million
Q2 2020 Aug 13, 2020	BUY	$128.7 - $176.83 $11.4 Million - $15.7 Million	88,510 Added 15.28%	667,810 $118 Million
Q1 2020 May 13, 2020	BUY	$121.39 - $169.05 $24 Million - $33.5 Million	198,000 Added 51.93%	579,300 $80.2 Million
Q4 2019 Feb 13, 2020	BUY	$133.47 - $153.48 $29.6 Million - $34 Million	221,700 Added 138.91%	381,300 $58.5 Million
Q3 2019 Nov 12, 2019	BUY	$135.4 - $146.47 $21.6 Million - $23.4 Million	159,600 New	159,600 $23.1 Million

2,511

542M

7.07M

4.55M

Ticker DHR
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 727,963,008
Market Cap $171B
Description
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...

Get notified when there are updates to the investment portfolio of Pactiv General Employee Benefit Trust, based on Form 13F filings with the SEC.

Stay updated on Pactiv General Employee Benefit Trust with notifications on news.